Gyre Therapeutics, Inc.

8-K Director or officer change; Regulation FD disclosure Jul 16, 2026 8-K/A Results of operations (earnings release) Jul 15, 2026 8-K Shareholder vote results Jun 16, 2026 8-K Regulation FD disclosure Jun 2, 2026 8-K Regulation FD disclosure May 14, 2026 8-K Regulation FD disclosure May 12, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Regulation FD disclosure May 4, 2026 8-K/A Entered a material agreement Apr 17, 2026 8-K Other events Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Regulation FD disclosure Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Mar 2, 2026 8-K Regulation FD disclosure Jan 5, 2026 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 7, 2025 8-K Other events Sep 10, 2025 8-K Director or officer change; Regulation FD disclosure Aug 22, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Aug 11, 2025 8-K Shareholder vote results Jun 6, 2025 8-K Entered a material agreement May 23, 2025 8-K Regulation FD disclosure; Other events May 22, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 9, 2025 8-K Regulation FD disclosure Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Results of operations (earnings release) Mar 17, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 18, 2025 8-K Director or officer change; Regulation FD disclosure Jan 6, 2025 8-K Entered a material agreement Nov 27, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Director or officer change; Regulation FD disclosure; Other events Aug 8, 2024 8-K Delisting notice or listing-rule failure; Director or officer change Jul 5, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 17, 2024